Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which trauma score best predicts who will die?

NCT ID NCT06709547

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers at a Baghdad hospital are comparing four trauma severity scoring systems, ISS, NISS, RTS, and TRISS, to see which one best predicts whether an injured patient will die in the hospital. The study follows 150 trauma patients admitted to the emergency department, calculating all four scores within 12 hours of arrival. The team then tracks outcomes such as death, length of stay, and ICU admission to measure how accurate each score turns out to be.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one score proves more accurate, hospitals could use it to flag the most severely injured patients sooner and direct intensive care where it is needed most.
What could go wrong
This is a single-center observational study of 150 patients, so its findings may not apply to other hospitals or populations. The scores are compared, not changed, and no new treatment is tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult trauma patients (≥18 years) presenting to the trauma and emergency department at Kadhimiya Educational Hospital in Baghdad. It includes individuals with acute injuries, such as blunt or penetrating trauma, who require trauma severity scoring. Data will be gathered through standardized clinical assessments and trauma scoring within the emergency department setting, ensuring a representative sample of the trauma population at the hospital.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Trauma patients admitted to the emergency room (ER). * Documented injury data sufficient to calculate both the New Injury Severity Score (NISS) and the Injury Severity Score (ISS). * Trauma scores (ISS, NISS, Revised Trauma Score \[RTS\], and Trauma and Injury Severity Score \[TRISS\]) calculated within 12 hour of arrival to ensure timely predictions. * Informed consent provided by the patient or a legal guardian in cases of incapacity. Exclusion Criteria: * Under 18 years of age and pregnant women, due to differences in trauma management and scoring applicability. * Non-trauma cases, including patients with terminal illnesses or severe cognitive impairments, to maintain focus on trauma outcomes. * Incomplete trauma scoring, missing or incomplete medical records, and * patients not treated in the trauma or emergency department. * Patients who refuse participation or withdraw consent to ensure ethical participation. * Transferred patients and those enrolled in other research studies that could interfere with trauma scoring.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Trauma, multiple are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

injury Multiple Trauma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • College of Medicine - Al-Nahrain University

    RECRUITING

    Baghdad, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.